Systemic inflammation and extra-articular manifestations in rheumatoid arthritis: a cross-sectional study

Karlygash Zharylkasynovna Sadykova, Gulnaz Orazbekovna Nuskabayeva, Ainash Oshibayeva, Shakhnoza Tatykayeva, Elmira Iskandirova, Arzu Yeskuatovna Mamutova, Aziza Djurabekova, U.B. Tatykayeva

Frontiers in Medicine, 2026

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.3389/fmed.2026.1814238
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Background Rheumatoid arthritis (RA) is a bodywide inflammatory condition that produces additional symptoms outside the joints that make the disease more severe and lead to patient disability and death. This research investigated various factors associated with the presence of extra-articular manifestations in RA patients. Methods The cross-sectional study was conducted from 2023 to 2025 and assessed 299 adult patients who received RA confirmation. Clinical assessments, laboratory tests, and instrumental results were evaluated for extra-articular manifestations, and univariable and multivariable logistic regression analyses were performed to examine these relationships. Results: Extra-articular manifestations were present in 278 patients (93%). Patients with extra-articular manifestations were older ( p = 0.039) and more frequently had disability (76% vs. 48%, p = 0.004). They also demonstrated higher levels of systemic inflammation, including C-reactive protein (median 20 vs. 11 mg/L, p = 0.015), erythrocyte sedimentation rate (36 vs. 21 mm/h, p < 0.001), rheumatic factor (92 vs. 55.2 IU/mL, p < 0.001), and higher antinuclear antibodies index values (1.5 vs. 0.43, p = 0.023). In the multivariable model, ESR remained independently associated with extra-articular manifestations (adjusted OR = 1.18, p < 0.001), while elevated white blood cell count was inversely associated (adjusted OR = 0.07, p = 0.001). Conclusions: Extra-articular manifestations in rheumatoid arthritis are most strongly associated with sustained systemic inflammation, as reflected by ESR, underscoring the importance of monitoring chronic inflammatory burden and the need for longitudinal studies to clarify causality and therapeutic implications.